logologo
QuantliQuantli

iBio Inc

IBIO

NASDAQ

Biotechnology

$1.43

USD

+0.03 (+2.14%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $69.55M

Volume 521.3K

Price Target

$5.00$5.00

USD

The 2 analysts offering 1-year price forecasts have a max estimate of $5.00 and a min estimate of $5.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$5.00

-$1.0 vs prior

Implied Upside

+249.7%

-69.9% vs prior

Analyst Covering

2

Unchanged vs prior period

Consensus

Buy

Unchanged vs prior

Signal Quality

Consensus Freshness

50%

A mix of recent and older ratings shape this consensus

Analyst Agreement

High

Targets are closely clustered - analysts agree more than usual

Mean vs Median

$0 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

2 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

2

Hold

0

Sell

0

Strong Sell

0

2 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Keay Nakae

Chardan Capital

Buy

Maintained

1 month ago

Plus
Plus
Plus

Martin Auster

Raymond James

Buy

Initiated

2 months ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

SPRO

Spero Therapeutics Inc

$1.23

-0.8%

ELTX

Elicio Therapeutics Inc

$3.09

-1.9%

PMVP

PMV Pharmaceuticals Inc

$1.26

+3.7%

GOSS

Gossamer Bio Inc

$0.1500

-9.4%

DWTX

Dogwood Therapeutics Inc

$2.15

+8.6%

CYPH

Cypherpunk Technologies Inc

$0.6400

-0.6%

RNTX

Rein Therapeutics Inc

$0.8100

+2.4%

CRDF

Cardiff Oncology Inc

$0.9600

-2.1%

TENX

Tenax Therapeutics Inc

$1.80

-1.6%

XBIT

XBiotech Inc

$2.30

-1.3%